NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?

Future Oncol. 2023 Mar;19(9):617-620. doi: 10.2217/fon-2023-0088. Epub 2023 May 2.
No abstract available

Keywords: NALIRIFOX; cancer; chemotherapy; pancreatic; survival.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Fluorouracil / therapeutic use
  • Humans
  • Irinotecan / therapeutic use
  • Leucovorin / therapeutic use
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / pathology

Substances

  • folfirinox
  • Irinotecan
  • Fluorouracil
  • Leucovorin